Access the full text.
Sign up today, get DeepDyve free for 14 days.
K. Wakasugi, A. Iida, T. Misaki, Y. Nishii, Y. Tanabe (2003)
Simple, Mild, and Practical Esterification, Thioesterification, and Amide Formation Utilizing p‐Toluenesulfonyl Chloride and N‐MethylimidazoleAdvanced Synthesis & Catalysis, 345
M. Fox, I. Lennon, V. Farina (2007)
Catalytic asymmetric synthesis of ethyl (1R,2S)-dehydrocoronamateTetrahedron Letters, 48
T. Sugasawa, T. Toyoda, M. Adachi, K. Sasakura (1978)
Aminohaloborane in organic synthesis. 1. Specific ortho substitution reaction of anilinesJournal of the American Chemical Society, 100
J. Schlütter (2011)
Therapeutics: New drugs hit the targetNature, 474
M. Llinàs-Brunet, M. Bailey, N. Goudreau, P. Bhardwaj, J. Bordeleau, M. Bös, Y. Bousquet, M. Cordingley, Jiamin Duan, P. Forgione, M. Garneau, É. Ghiro, V. Gorys, S. Goulet, T. Halmos, S. Kawai, J. Naud, M. Poupart, P. White (2010)
Discovery of a potent and selective noncovalent linear inhibitor of the hepatitis C virus NS3 protease (BI 201335).Journal of medicinal chemistry, 53 17
G. Samokhin, I. Filimonov (1985)
Coupling of peptides to protein carriers by mixed anhydride procedure.Analytical biochemistry, 145 2
G. Gfesser, E. Bayburt, M. Cowart, S. Didomenico, A. Gomtsyan, Chih-Hung Lee, A. Stewart, M. Jarvis, E. Kowaluk, S. Bhagwat (2003)
Synthesis and structure-activity relationships of 5-heteroatom-substituted pyridopyrimidines as adenosine kinase inhibitors.European journal of medicinal chemistry, 38 3
Hengli Tang, H. Grisé (2009)
Cellular and molecular biology of HCV infection and hepatitis.Clinical science, 117 2
I. Houpis, Audrey Molina, A. Douglas, L. Xavier, J. Lynch, R. Volante, P. Reider (1994)
Synthesis of a new generation reverse transcriptase inhibitor via the BCl3/GaCl3-induced condensation of anilines with nitriles (sugasawa reaction)Tetrahedron Letters, 35
K. Raney, Suresh Sharma, I. Moustafa, C. Cameron (2010)
Hepatitis C Virus Non-structural Protein 3 (HCV NS3): A Multifunctional Antiviral Target*The Journal of Biological Chemistry, 285
G. Barlin, W. Brown (1967)
Kinetics of reactions in heterocycles. Part III. Replacement of the methylsulphonyl group from quinoline, isoquinoline, quinoxaline, cinnoline, and phthalazine by methoxide ionJournal of The Chemical Society B: Physical Organic
C. Schotten
Ueber die Oxydation des PiperidinsEuropean Journal of Inorganic Chemistry, 17
M. Llinàs-Brunet, M. Bailey, G. Bolger, C. Brochu, A. Faucher, J. Ferland, M. Garneau, É. Ghiro, V. Gorys, C. Grand-Maître, T. Halmos, Nicole Lapeyre-Paquette, F. Liard, M. Poirier, M. Rhéaume, Y. Tsantrizos, D. Lamarre (2004)
Structure-activity study on a novel series of macrocyclic inhibitors of the hepatitis C virus NS3 protease leading to the discovery of BILN 2061.Journal of medicinal chemistry, 47 7
Laurent Chatel-Chaix, Martin Baril, D. Lamarre (2010)
Hepatitis C Virus NS3/4A Protease Inhibitors: A Light at the End of the TunnelViruses, 2
P. White, M. Llinàs-Brunet, M. Amad, R. Bethell, G. Bolger, M. Cordingley, J. Duan, M. Garneau, L. Lagacé, D. Thibeault, G. Kukolj (2010)
Preclinical Characterization of BI 201335, a C-Terminal Carboxylic Acid Inhibitor of the Hepatitis C Virus NS3-NS4A ProteaseAntimicrobial Agents and Chemotherapy, 54
G. Barlin, W. Brown (1967)
Kinetics of reactions in heterocycles. Part II. Replacement of the methylsulphonyl group in substituted pyridines, pyridazines, and pyrazine by methoxide ionJournal of The Chemical Society B: Physical Organic
E. Fischer (1903)
Synthese von PolypeptidenEuropean Journal of Inorganic Chemistry, 36
R. Frutos, N. Haddad, I. Houpis, Michael Johnson, Lana Smith-Keenan, V. Fuchs, N. Yee, V. Farina, A. Faucher, C. Brochu, B. Haché, J. Duceppe, P. Beaulieu (2006)
Practical Synthesis of 2-(2-Isopropylaminothiazol-4-yl)-7-methoxy-1H-quinolin-4-one: Key Intermediate for the Synthesis of Potent HCV NS3 Protease Inhibitor BILN 2061Synthesis, 2006
Z. Wróbel (1998)
Silane-mediated direct condensation of nitroarenes with cinnamyl-type sulfones. The way to 2-aryl-4-X-quinolines and their hetero analogsTetrahedron, 54
Jon Lorenz, C. Busacca, X. Feng, N. Grinberg, N. Haddad, Joe Johnson, S. Kapadia, Heewon Lee, A. Saha, Max Sarvestani, E. Spinelli, R. Varsolona, Xudong Wei, Xingzhong Zeng, C. Senanayake (2010)
Large-scale asymmetric synthesis of a cathepsin S inhibitor.The Journal of organic chemistry, 75 4
Y. Tsantrizos (2004)
The design of a potent inhibitor of the hepatitis C virus NS3 protease: BILN 2061—From the NMR tube to the clinicPeptide Science, 76
Michael Joyce, D. Tyrrell (2010)
The cell biology of hepatitis C virus.Microbes and infection, 12 4
P. Beaulieu, J. Gillard, M. Bailey, C. Boucher, J. Duceppe, B. Simoneau, Xiaojun Wang, L. Zhang, K. Grozinger, I. Houpis, V. Farina, Heidi Heimroth, T. Krueger, J. Schnaubelt (2005)
Synthesis of (1R,2S)-1-amino-2-vinylcyclopropanecarboxylic acid vinyl-ACCA) derivatives: key intermediates for the preparation of inhibitors of the hepatitis C virus NS3 protease.The Journal of organic chemistry, 70 15
E. Baumann (1886)
Ueber eine einfache Methode der Darstellung von BenzoësäureäthernEuropean Journal of Inorganic Chemistry, 19
K. Prasad, George Lee, A. Chaudhary, M. Girgis, James Streemke, O. Repič (2003)
Design of New Reaction Conditions for the Sugasawa Reaction Based on Mechanistic InsightsOrganic Process Research & Development, 7
A. Douglas, N. Abramson, I. Houpis, S. Karady, Audrey Molina, L. Xavier, N. Yasuda (1994)
In situ NMR spectroscopic studies of aniline ortho acylation (“sugasawa reaction”): The nature of reaction intermediates and Lewis acid influence on yieldTetrahedron Letters, 35
Steven Llinàs-Brunet (2005)
Dynamics and Structure-based Design of Drugs Targeting the Critical Serine Protease of the Hepatitis C Virus - From a Peptidic Substrate to BILN 2061Current Medicinal Chemistry - Anti-infective Agents, 4
D. Lamarre, P. Anderson, M. Bailey, P. Beaulieu, G. Bolger, P. Bonneau, M. Bös, D. Cameron, M. Cartier, M. Cordingley, A. Faucher, N. Goudreau, S. Kawai, G. Kukolj, L. Lagacé, S. LaPlante, H. Narjes, M. Poupart, J. Rancourt, R. Sentjens, R. George, B. Simoneau, G. Steinmann, D. Thibeault, Y. Tsantrizos, S. Weldon, C. Yong, M. Llinàs-Brunet (2003)
An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virusNature, 426
A concise synthetic route for large‐scale manufacture of the hepatitis C virus (HCV) protease inhibitor BI 201335 has been developed. A convergent synthetic design was achieved by using three advanced intermediates: a densely functionalized thiazole‐quinoline, a hydroxyproline‐containing dipeptide acid, and an optically pure vinylcyclopropane. Only three subsequent synthetic steps were then required for the final assembly of this complex target. The first step is a critical CO bond formation to join the heterocycle and the peptidic portion of the molecule, which was done by using a newly‐designed heterocyclic sulfone. The second step uses an inexpensive peptide coupling of the aminocyclopropane and ester saponification, then recrystallization completes the route. This economical and practical process is suitable for large scale production of BI 201335, requires no protecting groups or chromatography, and every isolated intermediate is a crystalline solid.
Asian Journal of Organic Chemistry – Wiley
Published: Sep 1, 2012
Keywords: ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.